⌘K

Login Start Free

Home/Filings/4/0001209191-12-019091

4//SEC Filing

Fanning Paul 4

Accession 0001209191-12-019091

CIK 0001093649other

View on SEC.gov Company Profile

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 10:40 AM ET

Size

8.4 KB

Accession

0001209191-12-019091

Insider Transaction Report

Form 4

Period: 2012-03-16

IDENIX PHARMACEUTICALS INCIDIX

SVP, Human Resources

Transactions

Exercise/Conversion
Common Stock
2012-03-16$2.41/sh+30,000$72,300→ 31,300 total
Sale
Common Stock
2012-03-16$11.04/sh−30,000$331,200→ 1,300 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-03-16−30,000→ 0 total
Exercise: $2.41Exp: 2017-11-08→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]This option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1

filerCIK 0001428086

Filing Metadata

Form type: 4
Filed: Mar 19, 8:00 PM ET
Accepted: Mar 20, 10:40 AM ET
Size: 8.4 KB

View on SEC.gov